CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 16, 2008--Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results